Avista Healthcare Partners Acquires Bentec to Expand MedTech Manufacturing
NEW YORK, April 8, 2026 Avista Healthcare Partners has announced the acquisition of Bentec Medical from Greyrock Capital Group...
Alzheimer’s Disease Autoimmune Disease Bio-Pharma biologics biopharma biopharma innovation Biotechnology cancer therapy Cell Therapy Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development FDA fda approval FDA clearance GCP Gene Therapy GMP Immuno-Oncology immunology Immunotherapy Medical Devices MedTech medtech innovation Monoclonal Antibody NSCLC Oncology oncology innovation Orphan Drug orphan drug designation patient access Phase 1 trial Phase 2 Trial Phase 3 trial Precision Medicine Precision Oncology rare disease rare diseases Regenerative Medicine regulatory approval regulatory compliance targeted therapy
NEW YORK, April 8, 2026 Avista Healthcare Partners has announced the acquisition of Bentec Medical from Greyrock Capital Group...
HERZLIYA, Israel, March 17, 2026 Regentis Biomaterials Ltd. has announced a breakthrough solvent-free manufacturing process for its lead regenerative...
WAYNE, PA — March 11, 2026 TekniPlex Healthcare, a global leader in advanced materials science and precision manufacturing for...
Minneapolis, U.S., and Brisbane, Australia, January 21, 2026 — Anteris Technologies Global Corp. announced the pricing of a $200...
NEW YORK | December 31, 2025 — Intelligent Bio Solutions announced a strategic manufacturing partnership with Syrma Johari MedTech,...
Tacares de Grecia, Alajuela, Costa Rica – December 9, 2025 – Forj Medical, the newly formed CDMO created by...
Eindhoven, Netherlands, November 3, 2025 — Medical-device CDMO VIVOLTA has signed a long-term agreement for a dedicated production facility...
